DOI QR코드

DOI QR Code

Cytomegalovirus Infection in Infantile Hepatitis

  • Na, So Young (Department of Pediatrics, Dongguk University College of Medicine)
  • Received : 2012.04.04
  • Accepted : 2012.06.13
  • Published : 2012.06.30

Abstract

Purpose: The aims of this study was to compare and evaluate the clinical characteristics, laboratory data, and prognosis for infants under age 1 year with CMV hepatitis and those with viral hepatitis of unknown etiology. Methods: A retrospective study was conducted of infants under age 1 year who were admitted with acute hepatitis. The exclusion criteria consisted of: autoimmune, genetic, metabolic, toxic, HAV, HBV, HCV, toxoplasma, rubella, herpes simplex, and Epstein-Barr virus. The 30 patients included were divided into two groups based on markers for CMV (IgM anti-CMV, CMV PCR in urine, CMV culture in urine). Results: The median age of patients (n=15) was 2.8 months. No other organ involvement was detected in any patient. Peak serum total bilirubin levels (n=4) ranged from 2.6 to 6.7 mg/dL. Peak serum ALT levels ranged from 51 to 1,581 IU/L. The duration of ALT elevation ranged from 1.5 weeks to 26 weeks (median 9 weeks). All had recovered in full without ganciclovir; there were no cases of hearing loss. The median age of controls (n=15) was 2.5 months. Peak serum total bilirubin levels (n=4) ranged from 1.6 to 9.1 mg/dL. Peak serum ALT levels ranged from 26 to 1,794 IU/L. No significant differences were observed between both groups regarding the peak serum ALT levels, peak serum total bilirubin levels, duration of hyperbilirubinemia and ALT elevation. Conclusion: Although it was not possible to differentiate congenital infection with perinatal infection in this study, the prognosis of patients with CMV hepatitis without other organ involvement was good without ganciclovir treatment.

Keywords

References

  1. Emerick K. Hepatitis in Children due to Non-A-E Viruses. In: Jonas MM. Viral Hepatitis in Children: Unique Features and Opportunities. 1st ed. New York: Humana Press, 2010:111-27.
  2. Funato T, Satou N, Abukawa D, Satou J, Abe Y, Ishii KK, et al. Quantitative evaluation of cytomegalovirus DNA in infantile hepatitis. J Viral Hepatol 2001; 8:217-22.
  3. Shibata Y, Kitajima N, Kawada J, Sugaya N, Nishikawa K, Morishima T, et al. Association of cytomegalovirus with infantile hepatitis. Microbiol Immunol 2005;49:771-7.
  4. Son SK, Park JH. Clinical features of non-A, B, C viral hepatitis in children. Korean J Pediatr Gastroenterol Nutr 2005;8:41-8.
  5. Stagno S, Britt W. Cytomegalovirus infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, eds. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: Saunders, 2006:739-81.
  6. Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med 2007;12:154-9.
  7. Yamamoto AY, Mussi-Pinhata MM, Cristina P, Pinto G, Moraes Figueiredo LT, Jorge SM. Congenital cytomegalovirus infection in preterm and full-term newborn infants from a population with a high seroprevalence rate. Pediatr Infect Dis J 2001;20:188-92.
  8. Chomel JJ, Allard JP, Floret D, Honneger D, David L, Lina B, et al. Role of cytomegalovirus infection in the incidence of viral acute respiratory infections in children attending day-care centers. Eur J Clin Microbiol Infect Dis 2001;20:167-72.
  9. Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med 2007;12:154-9.
  10. Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia: WB Saunders Co., 2008:851-915.
  11. Schleiss MR. Congenital cytomegalovirus infection: update on management strategies. Curr Treat Opinions Neurol 2008;10:186-92.
  12. Enright AM, Prober CG. Neurologic sequelae of congenital infection. In: Stevenson DK, Benitz WE, Sunshine P. Fetal and Neonatal Brain Injury: Mechanisms, Management, and the Risks of Practice. 3rd ed. Cambridge: Cambridge University Press, 2003:358-90.
  13. Stagno S. Cytomegalovirus. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson Textbook of Pediatrics. 18th ed. Philadelphia: WB Saunders Co., 2007;1377-9.
  14. AAP committee on infectious diseases. cytomegalovirus infection. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red book. 28th ed. Elk Grove Village, IL: American academy of pediatrics, 2009:275-80.
  15. Noyola DE, Demmler GJ, Williamson WD, Griesser C,Sellers S, Llorente A, et al. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J 2000;19:505-10.
  16. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002;15: 680-715.
  17. Sung SH, Park CI, Kim HG, Jung WH, Chung KS. Histopathologic appearance of cytomegaloviral liver diseases in neonates and infants. Korean J Pathol 1992;26:137-45.
  18. Lurie M, Elmalach I, Schuger L, Weintraub Z. Liver findings in infantile cytomegalovirus infection: similarity to extrahepatic biliary obstruction. Histopathology 1987;11:1171-80.
  19. Ljungman P, Plotkin SA. Workshop on CMV disease: definitions, clinical severity scores, and new syndromes. Scand J Infect Dis 1995;(99 Suppl):87S-9S.
  20. Katz SL, Gershon AA, Hotez PJ. Cytomegalovirus. In: Katz SL, Gershon AA, Hotez PJ. Krugman's infectious disease of children. 10th ed. St. Louis: Mosby, 1998; 37-56.
  21. Demmler-Harrison GJ. Cytomegalovirus. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, eds. Textbook of pediatric infectious diseases. 6th ed. Philadelphia: Saunders, 2009:2022-43.
  22. Kim CS. Congenital and perinatal cytomegalovirus infection. Korean J Pediatr 2010;53:14-20.
  23. Mussi-Pinhata MM, Yamamoto AY, do Carmo Rego MA, Pinto PC, da Motta MS, Calixto C. Perinatal or early- postnatal cytomegalovirus infection in preterm infants under 34 weeks gestation born to CMV-seropositive mothers within a high-seroprevalence population. J Pediatr 2004;145:685-8.
  24. Reynolds DW, Stagno S, Hosty TS, Tiller M, Alford CA Jr. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973;289:1-5.
  25. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999;180:702-7.
  26. Stehel EK, Sanchez PJ. Cytomegalovirus infection in the fetus and neonate. Neo Reviews 2005;6:e38-45.
  27. Hamprecht K, Maschmann J, Jahn G, Poets CF, Goelz R. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol 2008;41:198-205.
  28. Denson LA. Other viral infections. In: Walker WA, Goulet O, Kleinman RE, Sherman PM, Shneider BL, Sanderson IR. Pediatric Gastrointestinal Disease. 4th ed. Ontario: BC Decker Inc., 2004:1174-5.
  29. Nigro G, Krzysztofiak A, Bartmann U, Clerico A, Properzi E, Valia S, et al. Ganciclovir therapy for cytomegalovirus- associated liver disease in immunocompetent or immunocompromised children. Arch Virol 1997;142:573-80.
  30. Tezer H, Secmeer G, Kara A, Ceyhan M, Cengiz AB, Devrim I, et al. Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children. Turk J Pediatr 2008;50:228-34.
  31. Ozkan TB, Mistik R, Dikici B, Nazlioglu HO. Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis. BMC Gastroenterol 2007;7:9-13.
  32. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000;11:283-90.
  33. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hering loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997;130: 624-30.

Cited by

  1. Dynamic relationship between infantile hepatitis syndrome and cytomegalovirus infection vol.13, pp.6, 2012, https://doi.org/10.3892/etm.2017.4375
  2. Characteristics and prognosis of hepatic cytomegalovirus infection in children: 10 years of experience at a university hospital in Korea vol.60, pp.8, 2012, https://doi.org/10.3345/kjp.2017.60.8.261